This document is a published patent application from the USPTO detailing a novel composition for supporting nicotinamide adenine dinucleotide (NAD+) concentrations. The application, identified as US20260083765A1, outlines specific synergistic combinations of ingredients such as nicotinamide riboside, nicotinamide, nicotinic acid, B vitamins, magnesium, trans-resveratrol, and caffeine. The filing date for this application was September 20, 2024.

As this is a patent application, it does not impose immediate regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential future developments in the pharmaceutical and dietary supplement sectors related to NAD+ enhancement. Companies involved in the research, development, or manufacturing of related products should monitor the progress of this patent application and any subsequent granted patents, as they may impact intellectual property landscapes and market exclusivity for NAD+ boosting products.